Ketamine prevents seizures and reverses changes in muscarinic receptor induced by bicuculline in rats

Neurochemistry International

Volumn 62, Issue 3, 2013, Pages 258-264

  Schneider, Patricia Graciela ^a   Rodríguez De Lores Arnaiz, Georgina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Bicuculline; Experimental epilepsy; Ketamine; Muscarinic receptors; Seizures

Indexed keywords

BICUCULLINE; KETAMINE; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CEREBELLUM; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SINGLE DRUG DOSE;

ANIMALS; BICUCULLINE; CONVULSANTS; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SEIZURES;

RATTUS;

EID: 84873365110     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.12.013     Document Type: Article

References (41)

1. M.G. Annetta, D. Iemma, C. Garisto, C. Tafani, and R. Proietti Ketamine: new for an old drug Curr. Drug Targets 6 2005 789 794
2. R.F. Bell, C. Eccleston, and E. Kalso Ketamine as adjuvant to opiods for cancer pain. A qualitative systematic review J. Pain Symptom. Manage. 26 2003 867 875 (Pubitemid 37101234)
3. M. Belopavlovic, and A. Buchthal Modification of ketamine-induced intracranial hypertensión in neurosurgical patients by pretreatment with midazolam Acta Anaesthesiol. Scand. 26 1982 458 462 (Pubitemid 12000739)
4. D.J. Borris, E.H. Bertram, and J. Kapur Ketamine controls prolonged status epilepticus Epilepsy Res. 42 2000 117 122
5. A.O. Cunha, M.R. Mortari, J.L. Liberato, and W.F. dos Santos Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus Basic Clin. Pharmacol. Toxicol. 104 2009 470 477
6. M.E. Durieux Inhibition by ketamine of muscarinic acetylcholine receptor function Anesth. Analg. 81 1995 57 62
7. P.C. Emson Biochemical and metabolic changes in epilepsy A. Barbeau, R.J. Huxtable, Taurine and Neurological Disorders 1978 Raven Press New York 319 338
8. A.S. Evers, M. Crowder, and J.R. Balser General anesthetics L.L. Brunton, J.S. Lazo, K.L. Parker, Goodman and Gilman's The Pharmacological Basis of Therapeutics 2006 McGraw-Hill New York 341 368
9. E.J. Fitzgibbon, and R. Viola Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit J. Palliat. Med. 8 2005 49 57 (Pubitemid 40144251)
10. D.G. Fujikawa Neuroprotective effect of ketamine administered after status epilepticus onset Epilepsia 36 1995 186 195
11. R.S. Gable Acute toxic effects of club drugs J. Psychoactive Drugs 36 2004 303 313 (Pubitemid 39383167)
12. P.M. Gahlinger Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rophynol, and ketamine Am. Fam. Physician 69 2004 2619 2626
13. C. Grasshoff, T. Gillessen, E. Wagner, H. Thiermann, and L. Szinicz Ketamine reduces cholinergic modulated GABA release from rat striatal slices Toxicol. Lett. 156 2005 361 367 (Pubitemid 40342569)
14. G. Guler, F. Erdogan, A. Golgeli, A. Akin, and A. Boyaci Ketamine reduces lidocaine-induced seizures in mice Int. J. Neurosci. 115 2005 1239 1244 (Pubitemid 40992424)
15. C.Y. Hsieh, P.S. Sung, J.J. Tsai, and C.W. Huang Terminating prolonged refractory status epilepticus using ketamine Clin. Neuropharmacol. 33 2010 165 167
16. M. Irifune, T. Sato, Y. Kamata, T. Nishikawa, T. Dohi, and M. Kawahara Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice Anesth. Analg. 91 2000 230 236 (Pubitemid 30437092)
17. G. Ivani, C. Vercellino, and F. Tonetti Ketamine: a new look to an old drug Minerva Anestesiol. 69 2003 468 471 (Pubitemid 41750897)
18. O.H. Lowry, N. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
19. A. Manocha, K.K. Sharma, and P.K. Mediratta Possible mechanism of anticonvulsant effect of ketamine in mice Indian J. Exp. Biol. 39 2001 1002 1008 (Pubitemid 32961648)
20. B.S. Martin, and J. Kapur A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation Epilepsia 49 2008 248 255 (Pubitemid 351171997)
21. J. Mathew, G. Gangadharan, K.P. Kuruvilla, and C.S. Paulose Behavioral deficit and decreased GABA receptor functional regulation in the hippocampus of epileptic rats: effect of Bacopa monnieri Neurochem. Res. 36 2011 7 16
22. B.S. Meldrum The role of glutamate in epilepsy and other CNS disorders Neurology 44 1994 S14 S23
23. B.S. Meldrum Neurotransmission in epilepsy Epilepsia 36 1995 S30 S35
24. I.S. Midzyanovskaya, D.V. Salonin, D.Y. Bosnyakova, G.D. Kuznetsova, and E.L. van Luijtelaar The multiple effects of ketamine on electroencephalographic activity and behavior in WAG/Rij rats Pharmacol. Biochem. Behav. 79 2004 83 91 (Pubitemid 39237706)
25. P.A. Modica, R. Tempelhoff, and P.F. White Pro- and anticonvulsant effects of anesthetics (Part II) Anesth. Analg. 70 1990 433 444 (Pubitemid 20261308)
26. R.W. Olsen, and H. Betz GABA and glycine G.J. Siegel, R.W. Albers, S.T. Brady, M.D. Price, Basic Neurochemistry: Molecular, Cellular and Medical Aspects 2006 Elsevier Amsterdam 291 301
27. C.E. Ribak Epilepsy and the cortex A. Peters, Cerebral Cortex 1991 Plenum Publishing Co. New York 427 483
28. E. Roberts Failure of GABAergic inhibition: a key to local and global seizures A.V. Delgado-Escueta, A.A. Ward Jr. D.M. Woodbury, R.J. Porter, Advances in Neurology 1986 Raven Press New York 319 341
29. G. Rodríguez de Lores Arnaiz, M. Alberici de Canal, and E. De Robertis Alteration of GABA system and Purkinje cells in rat cerebellum by the convulsant 3-mercaptopropionic acid J. Neurochem. 19 1972 1379 1385
30. G. Rodríguez de Lores Arnaiz, M. Alberici de Canal, B. Robiolo, and M. Mistrorigo de Pacheco The effect of the convulsant 3-mercaptopropionic acid on enzymes of the γ-aminobutyrate system in the rat cerebral cortex J. Neurochem. 21 1973 615 623
31. L.M. Rowland Subanesthetic ketamine: how it alters physiology and behavior in humans Aviat. Space Environ. Med. 76 Suppl. 2005 C52 C58
32. C. Rubio, M. Rubio-Osornio, S. Retana-Marquez, M.L. Verónica Custodio, and C. Paz In vivo experimental models of epilepsy Cent. Nerv. Syst. Agents Med. Chem. 1 2010 298 309
33. 3H]-quinuclidinyl benzilate binding to membranes of the striatum and cerebellum Neurochem. Int. 20 1992 591 597
34. P.G. Schneider, and G. Rodríguez de Lores Arnaiz Ligand binding to CNS muscarinic receptor is transiently modified by convulsant 3-mercaptopropionic acid administration Neurochem. Res. 25 2000 637 643 (Pubitemid 30421997)
35. P.G. Schneider, and G. Rodríguez de Lores Arnaiz Area-dependent CNS membranes response of muscarinic receptor to convulsant 3-mercaptopropionic acid Mol. Chem. Neuropathol. 32 1997 1 9
36. P.G. Schneider, and G. Rodríguez de Lores Arnaiz Convulsant bicuculline modifies CNS muscarinic receptor affinity BMC Neurosci. 7 2006 32 39
37. H. Sprince, C.M. Parker, J.A. Josephs Jr., and J. Magazino Convulsant activity of homocysteine and other short-chain mercaptoacids: protection thereform Ann. N. Y. Acad. Sci. 166 1969 323 325
38. J. Velisková, L. Velisék, P. Mares, and R. Rokyta Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonic-clonic seizures during ontogenesis Pharmacol. Biochem. Behav. 37 1990 667 674
39. C.G. Wasterlain, and J.W. Chen Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs Epilepsia 49 Suppl. 9 2008 63 73
40. C.G. Wasterlain, D.B. Farber, and M.D. Fairchild Synaptic mechanisms in the kindled epileptic focus: a speculative synthesis A.V. Delgado-Escueta, A.A. Ward Jr. D.M. Woodbury, R.J. Porter, Advances in Neurology 1986 Raven Press New York 411 433
41. H.Y. Yamamura, and S.H. Snyder Muscarinic cholinergic binding in rat brain Proc. Natl. Acad. Sci. USA 71 1974 1725 1729